Expression Table for this CRE
| CNhs13831 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1 | 2.4 |
| CNhs14244 | carcinoid cell line:NCI-H727 | 1.8 |
| CNhs14241 | gastric cancer cell line:GSS | 1.5 |
| CNhs12700 | K562 erythroblastic leukemia response to hemin, day02, biol_rep2 | 1.2 |
| CNhs13836 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1 | 1.1 |
| CNhs14245 | lung adenocarcinoma, papillary cell line:NCI-H441 | 1.1 |
| CNhs13105 | Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7) | 1.1 |
| CNhs14239 | epithelioid sarcoma cell line:HS-ES-2R | 0.9 |
| CNhs10608 | Clontech Human Universal Reference Total RNA, pool1 | 0.9 |
| CNhs12060 | Skeletal Muscle Cells, donor6 | 0.9 |
| CNhs12641 | tenocyte, donor3 | 0.6 |
| CNhs12907 | H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41) | 0.5 |
| CNhs13367 | Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26) | 0.5 |
| CNhs12324 | putamen, adult, donor10196 | 0.5 |
| CNhs11978 | Endothelial Cells - Thoracic, donor2 | 0.5 |
| CNhs13637 | Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h) | 0.5 |
| CNhs14059 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3 | 0.4 |
| CNhs14189 | Smooth muscle cells - airway, asthmatic, donor6 | 0.4 |
| CNhs13361 | Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11) | 0.4 |
| CNhs12182 | CD8+ T Cells (pluriselect), donor090612, donation1 | 0.4 |
| CNhs14487 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3 | 0.4 |
| CNhs14410 | 293SLAM rinderpest infection, 06hr, biol_rep1 | 0.4 |
| CNhs13851 | Myoblast differentiation to myotubes, day04, control donor1 | 0.3 |
| CNhs13378 | Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59) | 0.3 |
| CNhs14467 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2 | 0.3 |
| CNhs10876 | Anulus Pulposus Cell, donor1 | 0.3 |
| CNhs14482 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1 | 0.3 |
| CNhs12660 | MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2 | 0.3 |
| CNhs13362 | Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14) | 0.3 |
| CNhs12882 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8) | 0.3 |
| CNhs14062 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2 | 0.3 |
| CNhs13344 | Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16) | 0.3 |
| CNhs12915 | H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21) | 0.2 |
| CNhs12906 | H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34) | 0.2 |
| CNhs13375 | Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50) | 0.2 |
| CNhs13224 | CD14+CD16- Monocytes, donor1 | 0.2 |
| CNhs10618 | cervix, adult, pool1 | 0.2 |
| CNhs11353 | Fibroblast - skin dystrophia myotonica, donor1 | 0.2 |
| CNhs12426 | MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1 | 0.2 |
| CNhs12390 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9) | 0.2 |
| CNhs12352 | CD19+ B Cells, donor2 | 0.2 |
| CNhs11047 | embryonic kidney cell line: HEK293/SLAM infection, 24hr | 0.1 |
| SRX6586327 | CNhi10316_MCF-7_Fluvastatin-30 uM-6h_rep3 | 0.1 |
| SRX6586323 | CNhi10316_MCF-7_Atrovastatin-30 uM-6h_rep2 | 0.1 |
| CNhs10643 | occipital pole, adult, pool1 | 0.1 |
| CNhs13223 | CD4+CD25-CD45RA+ naive conventional T cells, donor1 | 0.1 |
| CNhs12788 | K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3 | 0.1 |
| SRX6586324 | CNhi10316_MCF-7_Atrovastatin-30 uM-6h_rep3 | 0.1 |
| CNhs10635 | trachea, adult, pool1 | 0.1 |
| SRX6586325 | CNhi10316_MCF-7_Fluvastatin-30 uM-6h_rep1 | 0.1 |